Alphatec (ATEC) to Release Earnings on Wednesday

Alphatec (NASDAQ:ATEC) is projected to release its earnings data after the market closes on Wednesday, February 26th. Analysts expect Alphatec to post earnings of ($0.19) per share and revenue of $172.74 million for the quarter. Individual interested in registering for the company’s earnings conference call can do so using this link.

Alphatec Stock Performance

NASDAQ ATEC opened at $10.76 on Tuesday. Alphatec has a 12-month low of $4.88 and a 12-month high of $15.41. The firm has a 50-day moving average price of $10.50 and a two-hundred day moving average price of $8.30. The company has a market capitalization of $1.53 billion, a P/E ratio of -8.41 and a beta of 1.43. The company has a quick ratio of 1.15, a current ratio of 2.32 and a debt-to-equity ratio of 30.21.

Analysts Set New Price Targets

A number of equities research analysts recently issued reports on ATEC shares. HC Wainwright reissued a “buy” rating and set a $20.00 price target on shares of Alphatec in a research report on Tuesday, January 14th. Barclays upped their price objective on Alphatec from $20.00 to $21.00 and gave the stock an “overweight” rating in a research report on Wednesday, January 22nd. Finally, Needham & Company LLC boosted their target price on shares of Alphatec from $13.00 to $16.00 and gave the stock a “buy” rating in a research note on Monday, January 13th. One investment analyst has rated the stock with a hold rating and eight have given a buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $17.56.

Insider Activity at Alphatec

In other news, EVP David Sponsel sold 58,283 shares of Alphatec stock in a transaction dated Monday, January 13th. The stock was sold at an average price of $10.71, for a total value of $624,210.93. Following the completion of the transaction, the executive vice president now directly owns 502,311 shares of the company’s stock, valued at approximately $5,379,750.81. This trade represents a 10.40 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, COO Scott Lish sold 27,453 shares of the business’s stock in a transaction dated Thursday, February 6th. The shares were sold at an average price of $11.49, for a total value of $315,434.97. Following the completion of the transaction, the chief operating officer now directly owns 867,677 shares in the company, valued at $9,969,608.73. This represents a 3.07 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 222,376 shares of company stock worth $2,557,148 over the last ninety days. Insiders own 22.80% of the company’s stock.

About Alphatec

Alphatec Holdings, Inc, a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems.